The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open-label, multicenter trial of the concurrent chemoradiotherapy of capecitabine with or without oxaliplatin versus cisplatin with 5-FU for Chinese squamous esophageal cancer: An interim report from CRTCOESC.
 
Ruinuo Jia
No Relationships to Disclose
 
Tanyou Shan
No Relationships to Disclose
 
Fuyou Zhou
No Relationships to Disclose
 
Anping Zheng
No Relationships to Disclose
 
Lixin Wan
No Relationships to Disclose
 
Zhiqiao Xu
No Relationships to Disclose
 
Guobao Zheng
No Relationships to Disclose
 
Xiaoyong Luo
No Relationships to Disclose
 
Yingjuan Zheng
No Relationships to Disclose
 
Yanhui Cui
No Relationships to Disclose
 
Guifang Zhang
No Relationships to Disclose
 
Dan Zhou
No Relationships to Disclose
 
Jiachun Sun
No Relationships to Disclose
 
Guoqiang Kong
No Relationships to Disclose
 
Xiaozhi Yuan
No Relationships to Disclose
 
Ruina Yang
No Relationships to Disclose
 
Jing Ren
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Xinshuai Wang
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose